CIS
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC) (NCT01314664) | Endo USA Inc., a Keenova Therapeutics Company | 2011-05-01 |
| Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus (NCT01238042) | Roswell Park Cancer Institute | 2003-03-01 |
| Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus (NCT01236443) | Roswell Park Cancer Institute | 2000-08-01 |
Track CIS automatically
Every clearance here is in the API, with alerts when new ones post.